Breaking News
July 20, 2018 - Understanding triple-negative breast cancer to develop better treatments
July 20, 2018 - Study compares outpatient antibiotic prescribing with traditional medical, retail clinic settings
July 20, 2018 - Immediate Monitoring With ECG Patch Ups A-Fib Diagnosis Rate
July 20, 2018 - Scientists seek to better protect the eye from glaucoma
July 20, 2018 - Football training could improve bone mineral density in prostate cancer patients
July 20, 2018 - Single genetic change in gut bacteria can lead to obesity
July 20, 2018 - Research uncovers new target for therapeutic intervention in breast cancer
July 20, 2018 - WFN to highlight clean air for brain health on World Brain Day 2018
July 20, 2018 - Health Highlights: July 17, 2018
July 20, 2018 - Mom’s marijuana winds up in breast milk
July 20, 2018 - Black men could be healthier if seen by black physicians, new research suggests
July 20, 2018 - Alcoholics have persistent difficulties with emotional communication after long-term abstinence
July 19, 2018 - Researchers unravel how ALL invades the central nervous system
July 19, 2018 - Mother’s microbiome determines offspring’s risk of developing autism
July 19, 2018 - Refining standards of maternal-fetal care
July 19, 2018 - Stitching single cells together any which way you want to
July 19, 2018 - Study identifies RNA molecules that regulate male hormones in prostate cancer
July 19, 2018 - New machine-learning model shows promise in predicting undiagnosed dementia
July 19, 2018 - Sleep supports antioxidant processes, study suggests
July 19, 2018 - MiRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
July 19, 2018 - Unique brain ‘fingerprint’ can predict drug effectiveness
July 19, 2018 - Life on the border: Struggling to survive in Jordan
July 19, 2018 - CT scans may raise brain tumor risk
July 19, 2018 - Moderate alcohol intake linked with improved male fertility
July 19, 2018 - Alcohol-related cirrhosis mortality on the rise among young adults
July 19, 2018 - Study uncovers new protein complex that shields broken DNA ends
July 19, 2018 - Regular sunscreen use protects young people from melanoma
July 19, 2018 - Using non-invasive brain recordings to characterize activity in deep structures
July 19, 2018 - Mediterranean diet could influence academic performance through effects on sleep quality
July 19, 2018 - Woman’s pregnancy history may be linked to Alzheimer’s disease risk
July 19, 2018 - Study calls for new gold standard in research to treat non-alcoholic steatohepatitis
July 19, 2018 - Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions
July 19, 2018 - Scientists study adverse effects of carbon, silicon nanotubes and carbon nanofibers
July 19, 2018 - Keck Hospital of USC receives Magnet recognition for excellence in nursing
July 19, 2018 - Scientists identify hidden signals in RNAs that control protein synthesis
July 19, 2018 - Quadrivalent HPV Vaccine Not Tied to Spontaneous Abortion
July 19, 2018 - FDA OKs first drug made to reduce excessive sweating
July 19, 2018 - New Finnish study compares surgical treatment of shoulder impingement syndrome to placebo surgery
July 19, 2018 - New findings do no support caffeine as effective appetite suppressant or weight-loss aid
July 19, 2018 - Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers
July 19, 2018 - Study evaluates Neoteryx’s VAMS technology for monitoring HbA1c levels of diabetic children
July 19, 2018 - New clinical trial examines use of adrenaline to treat cardiac arrests
July 19, 2018 - Early surgical intervention may improve outcomes for patients with mitral valve disease
July 19, 2018 - Prolonged preoperative opioid use linked to adverse outcomes after total knee and hip arthroplasty
July 19, 2018 - Biophysicists use infrared sensor as new method for drug discovery
July 19, 2018 - Rat study shows negative effects of perinatal exposure to phthalates
July 19, 2018 - Children with disabilities endure long waits for life-changing medical equipment
July 19, 2018 - Ways to stay safe while camping and hiking
July 19, 2018 - People with HIV twice as likely to suffer from heart disease
July 19, 2018 - On-the-Job Stress Relief – MedNews
July 19, 2018 - Compounds found in green tea and wine may block formation of toxic metabolites
July 19, 2018 - Gene regulator associated with protein pileup in exfoliation glaucoma
July 19, 2018 - Trump administration summons immigrant infants
July 19, 2018 - FDA grants approval for first breast cancer drug through ‘Real-Time Oncology Review’
July 19, 2018 - Five tips for men seeking plastic surgery
July 19, 2018 - Researchers discover the reasons why some people get dizzy when hearing certain sounds
July 19, 2018 - Research project investigates snake venom treatment as antibiotic alternative for eye infections
July 19, 2018 - Melanoma could soon be detected using a blood test
July 19, 2018 - Exposure to bright light may have big impact on sleep-related behavior in children
July 19, 2018 - Deleting single gene in gut bacteria affects metabolism, reduces weight gain in mice
July 19, 2018 - New proteomics studies help gain more insights into Alzheimer’s, cancer and listeriosis
July 19, 2018 - Study finds major discrepancies in prescription drug labeling pregnancy information across four countries
July 19, 2018 - Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma
July 19, 2018 - Watching the immune system in action reveals what happens when things goes wrong
July 19, 2018 - Increasing blood sugar levels improves memory and performance in older adults
July 19, 2018 - Connection between self-regulation and obesity appears to be different for girls and boys
July 19, 2018 - Researchers develop new, less destructive method for whitening teeth
July 19, 2018 - Revving up innate control of viral infection requires a three-cell ignition
July 19, 2018 - Inaccurate direct-to-consumer raw genetic data can harm patients, new research suggests
July 19, 2018 - Weight loss surgery is effective under the right situations
July 19, 2018 - BioTek awarded patent for autofocus feature on microplate reader
July 19, 2018 - Low-carb diets reduce stiffness of arteries in women and promote weight loss in men
July 19, 2018 - New review examines cannabinoids’ potential for direct treatment of cancer
July 19, 2018 - Allergic responses may help protect the skin against cancer, research suggests
July 19, 2018 - Inappropriate Prescribing of Abx High in Urgent Care Centers
July 19, 2018 - Many at risk for HIV despite lifesaving pill
July 19, 2018 - Tips for doctors and parents on the harms of marijuana use for teens
July 18, 2018 - Researchers detect presence of IgE antibodies after kidney transplantation
July 18, 2018 - New technique allows researchers to create large scale, personalized bone grafts
July 18, 2018 - Smoking May Boost Atrial Fibrillation Risk
'Remarkable' effects introduced from new blood most cancers find out about

'Remarkable' effects introduced from new blood most cancers find out about

image_pdfDownload PDFimage_print
Electron microscopic symbol of a unmarried human lymphocyte. Credit score: Dr. Triche Nationwide Most cancers Institute

Scientists have described new result of a blood most cancers find out about as ‘exceptional’ in tackling up to now untreatable kinds of power lymphocytic leukaemia (CLL).

The development led through a crew from the College of Leicester and College Hospitals of Leicester NHS Agree with, inside the Hope Medical Trials Facility, concerned about treating sufferers with CLL.

It follows on from a world-first scientific trial of a brand new drug to regard explicit blood cancers. Result of that global scientific trial, led through Dr Harriet Walter and Professor Martin Dyer have been revealed within the magazine Blood in November 2015 and appeared on the efficacy of a brand new inhibitor, ONO/GS-4059, within the remedy of CLL and Non-Hodgkin Lymphoma sufferers, refractory or proof against present chemotherapies.

ONO/GS-4059 goals BTK, a protein crucial for the survival and proliferation of the tumour cells.

The find out about opened in January 2012 and 90 sufferers have been enrolled in several centres in the United Kingdom and in France, with 28 coming from Leicester. Sufferers with CLL confirmed the most efficient reaction and maximum of them have been nonetheless at the find out about after three years, and remarkably with out notable toxicities.

Within the new paper, the researchers are reporting for the long-term follow-up effects. Their paintings, revealed within the magazine Blood, was once funded through the Ernest and Helen Scott Haematological Analysis Institute, ONO Prescription drugs, Gilead Prescription drugs and the Most cancers Analysis UK Leicester Experimental Most cancers Drugs Centre. Native charity Hope Towards Most cancers fund the Medical Trials Facility based totally on the Leicester Royal Infirmary.

Professor Martin Dyer is Professor of Haemato-Oncology within the Division of Most cancers Research on the College of Leicester and Honorary Guide Doctor within the Division of Haematology at Leicester Royal Infirmary.

He mentioned: “This present paper describes the longer term keep on with up and presentations that during sufferers with CLL the remissions are sturdy and related with out a new toxicities. Moreover, in collaboration with Sistemas Genomicos, an organization in Valencia, we have now proven that mutations related to competitive illness reply neatly to remedy with ONO/GS-4059.

“Our long run keep on with up presentations maintained efficacy with out toxicity. This find out about is the primary document of long run follow-up of a selective BTK inhibitor – and it is superb information for sufferers.

“The consequences we’re presenting are according to a global scientific find out about involving the United Kingdom, France, Japan and US – and led through Leicester.

This was once a Section 1 scientific find out about because of this the researchers are within the early levels of trying out the drug’s effectiveness.

“We are actually doing research of ONO/GS-4059 together with different precision medications to evaluate whether or not those effects will also be enhanced in sufferers with CLL and different B cellular malignancies.”

Native most cancers analysis charity, Hope Towards Most cancers, has been investment a few of Professor Dyer’s paintings. Leader Govt of the charity, Nigel Rose mentioned: “Professor Dyer is a long-standing collaborator and recipient of Hope’s investment. We’re overjoyed that that is being put to such extraordinarily vital use in assembly our charity’s undertaking of bettering the lives of most cancers sufferers in the community.”

Discover additional:
Global-first blood most cancers drug trial finds life-changing effects

Additional info:
Harriet S. Walter et al. Lengthy-term follow-up of sufferers with CLL handled with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059, Blood (2017). DOI: 10.1182/blood-2017-02-765115

Magazine reference:

Equipped through:
College of Leicester

Tagged with:

About author

Related Articles